The objective of this study was to validate the Turkish version of the Quick Mild Cognitive Impairment (Qmci-TR) screen.
Methods:
In total, 100 patients aged ≥65 years referred to a geriatric outpatient clinic with memory loss were included. The Qmci was compared to the Turkish versions of the standardized Mini-Mental State Examination and the Montreal Cognitive Assessment (MoCA).
Results:
The Qmci-TR had higher accuracy than the MoCA in discriminating subjective memory complaints (SMCs) from cognitive impairment (mild cognitive impairment [MCI] or dementia), of borderline significance after adjusting for age and education (P = .06). The Qmci-TR also had higher accuracy than the MoCA in differentiating MCI from SMC, which became nonsignificant after adjustment (P = .15). A similar pattern was shown for distinguishing MCI from dementia. Test reliability for the Qmci-TR was strong.
Conclusion:
The Qmci-TR is a reliable and useful screening tool for discriminating MCI from SMC and dementia in a Turkish population.
RechelBGrundyERobineJM. Ageing in the European Union. Lancet. 2013;381(9874):1312–1322.
2.
PlassmanBLLangaKMFisherGG. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29(1-2):125–132.
3.
PlassmanBLLangaKMFisherGG. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med. 2008;148(6):427–434.
4.
PetersenRC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–194.
5.
PortetFOussetPJVisserPJ; MCI Working Group of the European Consortium on Alzheimer’s Disease (EADC). Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease. J Neurol Neurosurg Psychiatry. 2006;77(6):714–718.
6.
ShahYTangalosEGPetersenRC. Mild cognitive impairment. When is it a precursor to Alzheimer’s disease?Geriatrics. 2000;55(9):62, 65–68.
7.
ReitzCMayeuxR. Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia. J Alzheimer’s Dis. 2010;19(1):229–251.
8.
PetersenRCStevensJCGanguliMTangalosEGCummingsJLDeKoskyST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1133–1142.
JessenFAmariglioREvan BoxtelM; Subjective Cognitive Decline Initiative (SCD-I) Working Group. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimer’s Dementia. 2014;10(6):844–852.
11.
O’CaoimhRSatoSWallJ. Potential for a “Memory Gym” intervention to delay conversion of mild cognitive impairment to dementia. J Am Med Dir Assoc. 2015;16(11):998–999.
12.
Fiatarone SinghMAGatesNSaigalN. The Study of Mental and Resistance Training (SMART) study-resistance training and/or cognitive training in mild cognitive impairment: a randomized, double-blind, double-sham controlled trial. J Am Med Dir Assoc. 2014;15(12):873–880.
13.
PetersenRCThomasRGGrundmanM. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352(23):2379–2388.
NasreddineZSPhillipsNABedirianV. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699.
16.
SeleklerKCongozBUlucS. Power of discrimination of Montreal Cognitive Assessment (MoCA) Scale in Turkish patients with mild cognitive impairment and Alzheimer’s disease. Turk J Geriatr. 2010;13(3):166–171.
17.
KayaYAkiOECanUADerleEKibarogluSBarakA. Validation of Montreal Cognitive Assessment and siscriminant power of Montreal Cognitive Assessment subtests in patients with mild cognitive impairment and Alzheimer dementia in Turkish population. J Geriatr Psychiatry Neurol. 2014;27(2):103–109.
18.
OzdilekBKenangilG. Validation of the Turkish version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson’s disease. Clin Neuropsychol. 2014;28(2):333–343.
19.
MolloyDWStandishTILewisDL. Screening for mild cognitive impairment: comparing the SMMSE and the ABCS. Can J Psychiatry. 2005;50(1):52–58.
20.
BorsonSScanlanJMWatanabeJTuSPLessigM. Simplifying detection of cognitive impairment: comparison of the Mini-Cog and Mini-Mental State Examination in a multiethnic sample. J Am Geriatr Soc. 2005;53(5):871–874.
21.
HsiehSMcGrorySLeslieF. The Mini-Addenbrooke’s Cognitive Examination: a new assessment tool for dementia. Dement Geriatr Cogn Disord. 2015;39(1-2):1–11.
22.
O’CaoimhRGaoYMcGladeC. Comparison of the Quick Mild Cognitive Impairment (Qmci) screen and the SMMSE in screening for mild cognitive impairment. Age Ageing. 2012;41(5):624–629.
23.
O’CaoimhRGaoYGallagherPFEustaceJMcGladeCMolloyDW. Which part of the Quick Mild Cognitive Impairment screen (Qmci) discriminates between normal cognition, mild cognitive impairment and dementia?Age Ageing. 2013;42(3):324–330.
24.
O’CaoimhRSvendrovskiAJohnstonBC. The Quick Mild Cognitive Impairment screen correlated with the Standardized Alzheimer’s Disease Assessment Scale-cognitive section in clinical trials. J Clin Epidemiol. 2014;67(1):87–92.
25.
O’CaoimhRTimmonsSMolloyDW. Screening for Mild Cognitive Impairment: comparison of “MCI Specific” screening instruments. J Alzheimer’s Dis. 2016;51(2):619–629.
26.
ClarnetteRO’CaoimhRAntonyDSvendrovskiAMolloyDW. Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic [published online July 18, 2106]. Int J Geriatr Psychiatry. doi:10.1002/gps.4505.
27.
BuntSO’CaoimhRKrijnenWP. Validation of the Dutch version of the Quick Mild Cognitive Impairment screen (Qmci-D). BMC Geriatr. 2015;15:115.
28.
GohMO’CaoimhRSvendrovskiAMolloyDWClarnetteR. The Quick Mild Cognitive Impairment (Qmci) screen: validity and utility in an Australian population. Irish Ageing Stud Rev. 2015;6(1):347.
MarcLGRauePJBruceML. Screening performance of the 15-item Geriatric Depression Scale in a diverse elderly home care population. Am J Geriatr Psychiatry. 2008;16(11):914–921.
31.
McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology. 1984;34(7):939–944.
32.
American Psychiatric Association. DSM-5 Task Force. Diagnostic and statistical manual of mental disorders : DSM-5. 5th ed. Washington, D.C.: American Psychiatric Association; 2013.
FermanTJSmithGEKantarciK. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology. 2013;81(23):2032–2038.
36.
YoonJHLeeJEYongSWMoonSYLeePH. The mild cognitive impairment stage of dementia with Lewy bodies and Parkinson disease: a comparison of cognitive profiles. Alzheimer Dis Assoc Disord. 2014;28(2):151–155.
37.
de MendoncaARibeiroFGuerreiroMGarciaC. Frontotemporal mild cognitive impairment. J Alzheimer’s Dis. 2004;6(1):1–9.
O’CaoimhRGaoYSvendovskiAGallagherPEustaceJMolloyDW. Comparing Approaches to Optimize Cut-off Scores for Short Cognitive Screening Instruments in Mild Cognitive Impairment and Dementia. J Alzheimers Dis. 2017. doi: 10.3233/JAD-161204
40.
DamianAMJacobsonSAHentzJG. The Montreal Cognitive Assessment and the Mini-Mental State Examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord. 2011;31(2):126–131.
41.
MolloyDWAlemayehuERobertsR. Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination. Am J Psychiatry. 1991;148(1):102–105.
42.
MolloyDWStandishTI. A guide to the Standardized Mini-Mental State Examination. Int Psychoger. 1997;9(suppl 1):87–94; discussion 143-150.
43.
CunjeAMolloyDWStandishTILewisDL. Alternate forms of logical memory and verbal fluency tasks for repeated testing in early cognitive changes. Int Psychoger. 2007;19(1):65–75.
44.
FreitasSSimoesMRAlvesLSantanaI. Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord. 2013;27(1):37–43.
45.
ZhouSAZhuJZhangN. The influence of education on Chinese version of Montreal Cognitive Assessment in detecting amnesic mild cognitive impairment among older people in a Beijing rural community. Sci World J. 2014;2014:7.
JulayanontPTangwongchaiSHemrungrojnS. The Montreal Cognitive Assessment-Basic: a screening tool for mild cognitive impairment in illiterate and low-educated elderly adults. J Am Geriatr Soc. 2015;63(12):2550–2554.
48.
IversonGL. Sensitivity of computerized neuropsychological screening in depressed university students. Clin Neuropsychol. 2006;20(4):695–701.
